Rhabdoid tumour – Life with Disease

Go back

Rhabdoid tumour is a rare and highly aggressive childhood cancer that grows quickly and can spread throughout the body, most commonly affecting babies and toddlers under three years of age.

Understanding Prognosis in Rhabdoid Tumour

When families hear a diagnosis of rhabdoid tumour, one of the first questions that comes to mind is about what the future holds. This is an understandably difficult topic, and it’s important to approach it with both honesty and sensitivity. The outlook for children with rhabdoid tumours remains challenging, even with the most intensive treatment approaches available today.[1]

The prognosis for rhabdoid tumours is generally poor. These tumours are exceptionally aggressive, meaning they grow very rapidly and often spread to other parts of the body before treatment can fully control them. Although there have been some cases of long-term survival, particularly in children diagnosed after the age of two, most children with this condition face a very serious illness. Research indicates that children diagnosed at a younger age, particularly infants, tend to have a more difficult course than those diagnosed when they are slightly older.[25]

Statistics can provide some general understanding, though they cannot predict what will happen for any individual child. For atypical teratoid rhabdoid tumours—those affecting the brain and spinal cord—the five-year survival rate for children under 14 years old is approximately 47.8 percent. This means that about half of children diagnosed with this type of tumour survive for at least five years after diagnosis. However, this also means that many children do not survive that long, which reflects the serious nature of this disease.[23]

Several factors influence the outlook for each child. Where the tumour is located in the body, whether it has spread to other areas, how much of the tumour can be removed during surgery, and the child’s age at diagnosis all play important roles. Children who are diagnosed after age two and who do not have cancer that has spread beyond the original site tend to have better outcomes than younger infants or those with widespread disease. Even so, the overall prognosis remains guarded, and families should have detailed conversations with their child’s medical team about what to expect.[12]

⚠️ Important
Survival statistics are based on groups of children treated in the past and may not accurately predict what will happen for your child. Treatment approaches continue to improve, and every child’s situation is unique. Always discuss your child’s specific prognosis with their healthcare team, who can provide personalized information based on the individual circumstances of the disease.

Despite these challenges, research continues and there are reasons to hope. Medical centres that specialize in treating rhabdoid tumours have developed intensive treatment approaches that combine surgery, chemotherapy, radiation therapy, and sometimes stem cell transplants. Some children have responded well to these aggressive treatments and have achieved remission. Families who have more than a year and a half without recurrence after completing treatment may have better long-term prospects, though the risk of the cancer returning always remains a concern.[20]

How Rhabdoid Tumours Progress Without Treatment

Understanding how rhabdoid tumours develop and spread when left untreated helps explain why immediate and aggressive treatment is so critical. These tumours are fundamentally different from many other childhood cancers because of their exceptional speed of growth and their tendency to spread quickly throughout the body.[1]

Rhabdoid tumours begin when cells in a particular part of the body start growing out of control due to a genetic change. Most commonly, this happens in the kidneys, other soft tissues like muscles and organs, or in the brain and spinal cord. The cells that form these tumours look unusual under a microscope—they resemble cells called rhabdomyoblasts, which are immature muscle cells found in developing embryos. However, rhabdoid tumours are not actually muscle tumours; they just happen to look similar to these muscle cells, which is how they got their name.[1]

What makes rhabdoid tumours particularly dangerous is their aggressive nature. Without treatment, these tumours grow rapidly, often becoming quite large within a matter of weeks or even days. As the tumour expands, it puts pressure on surrounding tissues and organs, which causes many of the symptoms that lead to diagnosis. For example, a tumour in the brain may press against areas that control balance or breathing, while a tumour in the abdomen may create a visible lump and cause pain or digestive problems.[3]

The natural progression of rhabdoid tumours involves not just local growth but also the spread of cancer cells to distant parts of the body. This spreading process, called metastasis, can happen very early in the disease. Cancer cells can break away from the original tumour and travel through the bloodstream or other body fluids to establish new tumours in other locations. When rhabdoid tumours occur in one part of the body, they frequently spread through the central nervous system—the brain and spinal cord—even if they did not start there. Some children are found to have tumours in multiple locations at the time of diagnosis, meaning that the cancer has already spread before any treatment begins.[2]

The timeline of disease progression varies, but symptoms typically develop and worsen quickly because of how fast these tumours grow. Signs and symptoms may become noticeable over just days or weeks, rather than months or years as might be seen with slower-growing cancers. This rapid progression is why healthcare providers emphasize the need for immediate evaluation and treatment as soon as rhabdoid tumour is suspected or diagnosed.[9]

Possible Complications of Rhabdoid Tumour

Children with rhabdoid tumours face numerous potential complications, both from the disease itself and from the intensive treatments needed to fight it. Understanding these complications helps families prepare for what might lie ahead and allows them to work closely with the medical team to manage problems as they arise.

One of the most serious complications is the spread of cancer to other parts of the body. When rhabdoid tumours metastasize, they can establish new tumours in vital organs, making treatment much more difficult. The cancer may spread to the lungs, liver, bones, or throughout the brain and spinal cord. In some cases, children develop what doctors call multifocal synchronous tumours, which means they have multiple primary tumours that developed independently in different locations at the same time. This complication significantly worsens the prognosis and requires even more intensive treatment.[5]

The location of the tumour itself can lead to serious complications even before it spreads. Brain tumours can cause increased pressure inside the skull, leading to severe headaches, vomiting, seizures, and changes in consciousness. They may also damage critical areas that control breathing, heart rate, balance, or coordination. Tumours in the kidneys can cause bleeding, blood in the urine, or kidney failure. Tumours in the chest can interfere with breathing, while those in the abdomen can block the intestines or cause internal bleeding.[1]

Treatment complications are also significant because rhabdoid tumours require very aggressive therapy. High-dose chemotherapy, which is necessary to kill the fast-growing cancer cells, can severely damage the bone marrow—the spongy tissue inside bones that produces blood cells. When bone marrow is damaged, the body cannot make enough red blood cells to carry oxygen, white blood cells to fight infections, or platelets to help blood clot. This puts children at high risk for serious infections, severe anemia, and dangerous bleeding problems.[9]

Radiation therapy, especially to the brain, can have both immediate and long-term effects. In young children, radiation can damage developing brain tissue, potentially affecting cognitive development, learning, memory, and behavior. It may also impact growth hormones, vision, hearing, and the development of secondary sexual characteristics later in life. Because many children with rhabdoid tumours are very young, these developmental concerns are particularly significant.[17]

Surgery carries its own set of risks, particularly when tumours are large or located in difficult-to-reach areas. Removing a brain tumour may cause damage to surrounding healthy brain tissue, leading to neurological problems. Surgery for kidney tumours might affect kidney function, and operations for tumours in the chest or abdomen can be complicated by the tumour’s size and involvement with other organs.[2]

Children who require stem cell transplants face additional complications. The high-dose chemotherapy given before transplant can cause severe side effects including mouth sores, digestive problems, liver damage, and overwhelming infections. The recovery period after transplant can be lengthy and requires careful monitoring for signs of complications such as graft-versus-host disease if donated cells are used, or for infections while the immune system rebuilds.[9]

Even after successful initial treatment, late complications can emerge. Children who survive rhabdoid tumours may develop secondary cancers later in life due to the genetic changes that caused their original cancer or as a result of the intensive treatments they received. They may also experience ongoing health problems related to organ damage from chemotherapy, radiation effects on growth and development, or psychological impacts from their childhood cancer experience.[20]

⚠️ Important
Not every child will experience all of these complications. The medical team will closely monitor your child throughout treatment and can provide supportive care to prevent or manage many of these problems. Modern pediatric oncology centres have expertise in minimizing complications while still providing the intensive treatment needed to fight this aggressive cancer.

Impact on Daily Life

A diagnosis of rhabdoid tumour changes every aspect of daily life for the child and their entire family. The disease and its treatment create physical, emotional, practical, and social challenges that affect everyone involved. Understanding these impacts can help families prepare and find ways to cope with the dramatic changes that lie ahead.

For the child, physical limitations begin almost immediately. Depending on where the tumour is located, they may experience pain, difficulty moving, problems with balance or coordination, or weakness. A young infant with a brain tumour might become unusually sleepy, fussy, or lose interest in eating. Older toddlers might stop walking steadily, lose skills they had recently learned, or show changes in their personality and behavior. These changes can be frightening for both the child and their parents.[1]

Once treatment begins, the physical challenges intensify. Chemotherapy often causes severe nausea and vomiting, loss of appetite, mouth sores that make eating painful, and extreme fatigue. Children lose their hair, which can be distressing even for very young children who notice the change. They may need to have a central line or port surgically placed in their chest to receive medications, which can be uncomfortable and requires special care. Frequent blood tests mean repeated needle sticks, though accessing the port can make this somewhat easier.[12]

The treatment schedule itself completely disrupts normal family life. Children with rhabdoid tumours typically require many months of intensive therapy, including extended hospital stays, daily radiation treatments over several weeks, and frequent clinic visits for chemotherapy and monitoring. Families often need to travel to specialized cancer centers, sometimes far from home, and may need to relocate temporarily to be close to the hospital. This upheaval affects not just the sick child but also siblings, who may need to stay with relatives or adjust to having their parents absent for extended periods.[2]

Emotionally, the impact is profound for everyone. Parents face overwhelming stress from worry about their child’s survival, the intensity of watching their child suffer through treatment, and the uncertainty about the future. They must make difficult decisions about treatment options while dealing with their own grief and fear. Siblings may feel confused, scared, or resentful about the attention focused on the sick child. They might worry that they somehow caused their sibling’s illness or fear getting sick themselves. Even very young children can sense the anxiety and sadness in their family.[20]

Social isolation becomes a significant issue. During treatment, especially after chemotherapy that weakens the immune system, children must avoid exposure to infections. This means no daycare, no playgroups, no public playgrounds, and limited contact with other children. Family visits may be restricted, and the child misses normal childhood experiences like birthday parties or holiday gatherings. For the parents, there is often little time or energy for maintaining friendships or participating in normal social activities.[9]

Financial pressures add another layer of stress. Even with insurance, medical bills can be overwhelming. One or both parents often need to reduce work hours or leave their jobs entirely to care for the sick child. Travel costs, parking fees, meals away from home, and accommodation near the hospital all add up. Some families face the loss of their home or file for bankruptcy while trying to pay for their child’s care.

For families trying to cope with these challenges, support systems become essential. Many hospitals have social workers, child life specialists, and psychologists who can provide counseling and practical assistance. Support groups—either in person or online—allow parents to connect with others facing similar situations. Organizations dedicated to childhood cancer may provide financial assistance, lodging near hospitals, or other practical help. Some families find comfort in their faith communities or extended family networks.

Maintaining some sense of normalcy where possible helps everyone cope. Simple activities like reading stories together, playing gentle games during hospital stays, or celebrating small milestones can provide comfort and distraction. Helping siblings understand what is happening in age-appropriate ways and ensuring they receive individual attention helps them feel included and valued. Some families benefit from keeping a journal or blog to document the journey and stay connected with their wider support network.[20]

Support for Families Considering Clinical Trials

Because rhabdoid tumours are so rare and aggressive, many families find themselves considering participation in clinical trials as part of their child’s treatment. Understanding what clinical trials are, how they might benefit children with this disease, and how families can support their child through this process is important for making informed decisions.

Clinical trials are research studies that test new ways to prevent, detect, or treat diseases. For rare cancers like rhabdoid tumours, there is no single “standard” treatment that has been proven to work best because the disease is so uncommon that large studies are difficult to conduct. This means that treatment approaches continue to evolve, and doctors must tailor therapy to each child’s situation. Clinical trials offer access to the newest treatment approaches that show promise but are still being studied.[2]

Families should understand that participating in a clinical trial does not mean their child will receive less effective care or be treated like a “guinea pig.” Clinical trials are carefully designed to test whether new treatments might work better than current approaches, and they include strong safeguards to protect children. All children in trials receive close monitoring and expert care from specialized medical teams. Many of the treatment advances that have improved outcomes for childhood cancers came from earlier clinical trials.[2]

When considering a clinical trial, families can support their child by gathering information and asking questions. They should learn what the trial is testing, what treatments their child would receive, how these compare to standard treatments, what the possible risks and benefits are, and what extra tests or procedures might be needed. The research team must provide detailed information and obtain informed consent before enrollment, but families should feel empowered to ask as many questions as needed until they feel comfortable with their decision.

Supporting a child through a clinical trial involves many of the same approaches as supporting them through standard treatment. Maintaining open, age-appropriate communication helps children understand what to expect. Even very young children benefit from simple explanations about what will happen and reassurance that their parents and doctors are working together to help them feel better. Older children might appreciate being included in discussions about their care in ways that respect their developing understanding and autonomy.

Practical support matters greatly. Families should work with the trial coordinators and social workers to understand the schedule of appointments, treatments, and tests. Organizing transportation, arranging care for siblings, and managing the logistics of treatment help reduce stress. Many clinical trials have research coordinators or nurses who serve as a point of contact and can help families navigate the process.

Emotionally, families benefit from connecting with other parents who have been through similar experiences. Many cancer centers can put families in touch with others whose children participated in trials, though privacy is always respected. Online communities for parents of children with rare cancers can also provide support and shared experiences. Knowing that participating in a trial might help other children in the future, even if the outcome for their own child is uncertain, provides some families with a sense of purpose during an incredibly difficult time.

Families should also know that they can withdraw from a clinical trial at any time if they decide it is not right for their child. This will not affect the quality of care their child receives, and doctors will work with them to determine the best alternative treatment approach. The decision to participate in research is deeply personal and should be made based on what feels right for each individual family and child.

💊 Registered drugs used for this disease

Based on the available sources, the following types of chemotherapy drugs are mentioned as part of treatment for rhabdoid tumours, though specific brand names are limited:

  • Cyclophosphamide – A chemotherapy drug used to kill fast-growing cancer cells in rhabdoid tumours
  • Cisplatin – A chemotherapy agent used in combination therapy to treat malignant rhabdoid tumours
  • Etoposide (Vepesid) – A chemotherapy medication that helps destroy cancer cells
  • Vincristine – A chemotherapy drug used as part of combination treatment regimens
  • Carboplatin – A platinum-based chemotherapy agent used to treat rhabdoid tumours
  • Ifosfamide (Ifex) – A chemotherapy drug used in high-dose treatment protocols
  • Doxorubicin – A chemotherapy medication used in combination regimens for rhabdoid tumours
  • Methotrexate – A chemotherapy agent used in treatment protocols
  • Thiotepa (Tepadina) – A chemotherapy drug sometimes used before stem cell transplant
  • Cytarabine (Cytosar) – A chemotherapy medication used in treatment combinations

Ongoing Clinical Trials on Rhabdoid tumour

  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Spain

References

https://my.clevelandclinic.org/health/diseases/24440-rhabdoid-tumor

https://www.childrenshospital.org/conditions/malignant-rhabdoid-tumor

https://rarediseases.info.nih.gov/diseases/7572/rhabdoid-tumor

https://www.dana-farber.org/cancer-care/types/childhood-malignant-rhabdoid-tumor

https://medlineplus.gov/genetics/condition/rhabdoid-tumor-predisposition-syndrome/

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rhabdoid-tumor

https://en.wikipedia.org/wiki/Malignant_rhabdoid_tumour

https://www.chop.edu/conditions-diseases/rhabdoid-tumor-predisposition-syndrome

https://www.schn.health.nsw.gov.au/rhabdoid-tumours-factsheet

https://my.clevelandclinic.org/health/diseases/24440-rhabdoid-tumor

https://www.dana-farber.org/cancer-care/types/childhood-malignant-rhabdoid-tumor

https://pmc.ncbi.nlm.nih.gov/articles/PMC8841298/

https://www.cancer.gov/types/brain/patient/child-cns-atrt-treatment-pdq

https://kidshealth.org/en/parents/rhabdoid-liver.html

https://www.childrenshospital.org/conditions/malignant-rhabdoid-tumor

https://www.nicklauschildrens.org/conditions-we-treat/rhabdoid-tumor

https://cancer.ca/en/cancer-information/cancer-types/brain-and-spinal-cord-childhood/treatment/rhabdoid-tumours

https://my.clevelandclinic.org/health/diseases/24440-rhabdoid-tumor

https://www.childrenshospital.org/conditions/malignant-rhabdoid-tumor

https://blog.dana-farber.org/insight/2020/01/for-families-facing-malignant-rhabdoid-tumors-reasons-to-hope/

https://www.medicalnewstoday.com/articles/rhabdoid-tumor-cancer

https://together.stjude.org/en-us/conditions/cancers/atypical-teratoid-rhabdoid-tumor-atrt.html

https://www.abta.org/tumor_types/atypical-teratoid-rhaboid-tumor-atrt/

https://kidshealth.org/en/parents/rhabdoid-liver.html

https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/extra-cranial-rhabdoid-tumor

FAQ

What causes rhabdoid tumours in babies?

Rhabdoid tumours are caused by genetic changes (mutations) in a gene called SMARCB1 in about 90% of cases, and rarely by mutations in the SMARCA4 gene. These are tumor suppressor genes that normally help control cell growth. While some children inherit these mutations from a parent, most cases occur due to new spontaneous genetic changes with no family history of the condition.

How quickly do rhabdoid tumours grow?

Rhabdoid tumours are extremely fast-growing cancers. Symptoms often develop and worsen over just days or weeks rather than months. This rapid growth is why immediate medical attention and aggressive treatment are critical once the disease is suspected or diagnosed.

Can rhabdoid tumours be cured?

While rhabdoid tumours are very difficult to treat and the overall prognosis remains challenging, some children have achieved long-term survival with intensive treatment combining surgery, chemotherapy, radiation therapy, and sometimes stem cell transplants. Children diagnosed after age 2 without widespread disease tend to have better outcomes than younger infants, though the disease remains serious for all patients.

What is the difference between MRT and ATRT?

MRT stands for malignant rhabdoid tumor, which occurs in the kidneys and other soft tissues outside the brain. ATRT stands for atypical teratoid rhabdoid tumor, which occurs in the brain and spinal cord. Both are the same type of aggressive cancer with similar genetic causes, but they are classified differently based on where they develop in the body.

Will my other children get rhabdoid tumours?

Most rhabdoid tumours occur due to new genetic mutations that happen spontaneously and are not inherited from parents. However, in rare cases, the mutation can be inherited. If a child has a rhabdoid tumour, genetic counseling and testing may be recommended for the family to determine if there is a hereditary form and assess the risk for other children.

🎯 Key takeaways

  • Rhabdoid tumours are extremely rare, affecting fewer than 1 in 1 million people, with most cases occurring in babies between 11 and 18 months old
  • These tumours grow and spread exceptionally quickly, which is why symptoms often worsen over just days or weeks
  • Nearly 90% of rhabdoid tumours involve mutations in the SMARCB1 gene, a tumor suppressor that normally controls cell growth
  • Treatment typically requires a combination of surgery, high-dose chemotherapy, radiation therapy, and sometimes stem cell transplant
  • Children can develop rhabdoid tumours in multiple locations simultaneously, suggesting these are independent primary tumours rather than spread from one site
  • About 20 to 25 new cases of malignant rhabdoid tumours are diagnosed each year in the United States
  • The five-year survival rate for children under 14 with brain-based rhabdoid tumours is approximately 48%, reflecting the serious nature of this disease
  • Because rhabdoid tumours are so rare, there is no standard treatment protocol, and care is often tailored to each child’s individual situation through specialized cancer centers